Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""McDonald EG"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 23
Tytuł:
Multidisciplinary Teams for the Management of Infective Endocarditis: A Systematic Review and Meta-analysis.
Autorzy:
Roy AS; Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
Hagh-Doust H; Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
Abdul Azim A; Division of Infectious Diseases, Allergy and Immunology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Caceres J; Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan, USA.
Denholm JT; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Australia.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Dong MQD; Antimicrobial Stewardship Pharmacy, New York Health and Hospitals, Bellevue Hospital, New York City, New York, USA.
King M; Outpatient Antimicrobial Stewardship Clinical Pharmacy, Cooper University Healthcare, Camden, New Jersey, USA.
Yen CF; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Lee TC; Clinical Practice Assessment Unit, McGill University Health Centre, Montreal, Canada.; Division of Infectious Diseases, McGill University Health Centre, Montreal, Canada.
McDonald EG; Clinical Practice Assessment Unit, McGill University Health Centre, Montreal, Canada.; Division of General Internal Medicine, McGill University Health Centre, Montreal, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Aug 21; Vol. 10 (9), pp. ofad444. Date of Electronic Publication: 2023 Aug 21 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.
Autorzy:
Reiersen AM; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Mattar C; Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Bender Ignacio RA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Allergy & Infectious Diseases Division, Department of Medicine, University of Washington, Seattle, Washington, USA.
Boulware DR; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Department of Medicine, Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, Québec, Canada.; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Québec, Canada.
Hess R; Division of Health System Innovation and Research, University of Utah, Salt Lake City, Utah, USA.; Division of General Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Lankowski AJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
McDonald EG; Department of Medicine, Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, Québec, Canada.; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Québec, Canada.; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Miller JP; Institute for Informatics, Data Science and Biostatistics, Washington University School of Medicine, St. Louis, Missouri, USA.
Powderly WG; Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Pullen MF; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Rado JT; Departments of Psychiatry & Behavioral Sciences and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Rich MW; Department of Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
Schiffer JT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Allergy & Infectious Diseases Division, Department of Medicine, University of Washington, Seattle, Washington, USA.
Schweiger J; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Spivak AM; Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA.
Stevens A; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Vigod SN; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto and Women's College Hospital, Toronto, Ontario, Canada.
Agarwal P; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto and Women's College Hospital, Toronto, Ontario, Canada.
Yang L; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Yingling M; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Gettinger TR; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Zorumski CF; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Lenze EJ; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Aug 08; Vol. 10 (8), pp. ofad419. Date of Electronic Publication: 2023 Aug 08 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials.
Autorzy:
Mitjà O; Fight AIDS and Infectious Diseases Foundation, Barcelona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Lihir Medical Center-International SOS, Lihir Island, Papua New Guinea.
Reis G; Research Division, Cardresearch Cardiologia Assistencial e de Pesquisa, Pontifícia Universidade Católica de Minas Gerais, Bello Horizonte, Brazil.; Cytel Inc., Vancouver, British Columbia, Canada.
Boulware DR; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Spivak AM; University of Utah, Salt Lake City, Utah, USA.
Sarwar A; Harvard Medical School, Boston, Massachusetts, USA.
Johnston C; Department of Medicine and Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Webb B; Intermountain Health Care, University of Utah, Salt Lake City, Utah, USA.
Hill MD; University of Calgary, Calgary, Alberta, Canada.
Smith D; Division of Infectious Diseases & Global Public Health, UC San Diego School of Medicine, San Diego, California, USA.
Kremsner P; University Hospital of Tübingen, Tübingen, Germany.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Curran M; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
Carter D; MMS Holdings, Canton, Michigan, USA.
Alexander J; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
Corbacho M; Fight AIDS and Infectious Diseases Foundation, Barcelona, Spain.
Lee TC; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Hullsiek KH; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
McDonald EG; Division of General Internal Medicine, McGill University Health Center, Montreal, Quebec, Canada.
Hess R; University of Utah, Salt Lake City, Utah, USA.
Hughes M; Harvard Medical School, Boston, Massachusetts, USA.
Baeten JM; Department of Medicine and Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Schwartz I; University of Alberta, Edmonton, Canada.
Metz L; University of Calgary, Calgary, Alberta, Canada.
Richer L; University of Alberta, Edmonton, Canada.
Chew KW; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, California, USA.
Daar E; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Wohl D; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Dunne M; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Mar; Vol. 16 (3), pp. 524-535. Date of Electronic Publication: 2023 Jan 04.
Typ publikacji:
Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Adult ; Humans ; COVID-19 Drug Treatment ; Hydroxychloroquine ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV.
Autorzy:
Davar K; Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, California, USA.
Clark D; Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, California, USA.
Centor RM; Department of Medicine, Birmingham Veterans Affairs (VA) Medical Center, Birmingham, Alabama, Birmingham, Alabama, USA.
Dominguez F; Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, California, USA.
Ghanem B; King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Lee R; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, Canada.
McDonald EG; Division of General Internal Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Phillips MC; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Sendi P; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Spellberg B; Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Dec 29; Vol. 10 (1), pp. ofac706. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis.
Autorzy:
Ryder JH; Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Tong SYC; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Gallagher JC; Department of Pharmacy Practice, Temple University, Philadelphia, Pennsylvania, USA.
McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Thevarajan I; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Cortés-Penfield NW; Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Oct 31; Vol. 9 (11), pp. ofac583. Date of Electronic Publication: 2022 Oct 31 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.
Autorzy:
Beck A; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. .
Persaud N; Department of Family and Community Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
Tessier LA; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Grad R; Department of Family Medicine, McGill University, Montreal, Quebec, Canada.
Kidd MR; College of Health & Medicine, The Australian National University, Canberra, Australia.; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Klarenbach S; Department of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Korownyk C; Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
Moore A; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Thombs BD; Lady Davis Institute of the Jewish General Hospital and Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Mangin D; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of General Practice, University of Otago, Dunedin, New Zealand.
McCracken RK; Department of Family Practice, University of British Columbia, Vancouver, British Columbia, Canada.
McDonald EG; Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Sirois C; Faculty of Pharmacy, Laval University; Centre d'excellence sur le vieillissement de Québec, VITAM research Centre, Québec, Québec, Canada.
Kanji S; The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Molnar F; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Division of Geriatric Medicine, The Ottawa Hospital, The Ottawa Hospital Research Institute, Bruyere Research Institute, Ottawa, Ontario, Canada.
Nicholls SG; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Thavorn K; Independent Information Specialist, Ottawa, Ontario, Canada.
Bennett A; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Shaver N; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Skidmore B; Independent Information Specialist, Ottawa, Ontario, Canada.
Mitchelmore BR; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Avey M; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Rolland-Harris E; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Little J; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Moher D; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2022 Oct 20; Vol. 11 (1), pp. 225. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Inappropriate Prescribing*/prevention & control
Quality of Life*
Humans ; Adult ; Canada ; Bias ; Primary Health Care ; Systematic Reviews as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial.
Autorzy:
Williams J; Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
Gingras MA; Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
Dubé R; Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
Lee TC; Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
McDonald EG; Department of Medicine (Williams, Gingras, Dubé, Lee, McDonald), McGill University; Clinical Practice Assessment Unit (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que. emily.mcdonald@mcgill.ca.
Pokaż więcej
Źródło:
CMAJ open [CMAJ Open] 2022 Jul 12; Vol. 10 (3), pp. E652-E656. Date of Electronic Publication: 2022 Jul 12 (Print Publication: 2022).
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Deprescriptions*
Pamphlets*
gamma-Aminobutyric Acid*/adverse effects
Aftercare ; Humans ; Patient Discharge ; Patient Participation ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality.
Autorzy:
Bai AD; Division of Infectious Diseases, Department of Medicine, Queen's University, Kingston, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Lo CKL; Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Komorowski AS; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.; Division of Medical Microbiology, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Suresh M; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Guo K; Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Garg A; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Tandon P; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Senecal J; Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
Del Corpo O; Department of Medicine, Division of Experimental Medicine, Division of Infectious Diseases, McGill University, Montreal, Quebec, Canada.
Stefanova I; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Fogarty C; McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
Butler-Laporte G; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Cheng MP; Divisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Montreal, Quebec, Canada.
Morris AM; Division of Infectious Diseases, Department of Medicine, Sinai Health, University Health Network, and the University of Toronto, Toronto, Ontario, Canada.
Loeb M; Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Apr 10; Vol. 9 (5), pp. ofac096. Date of Electronic Publication: 2022 Apr 10 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outpatient Therapies for COVID-19: How Do We Choose?
Autorzy:
Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Division of Clinical Epidemiology, Department of Medicine, McGill University, Montréal, Québec, Canada.
Morris AM; Division of Infectious Diseases, Department of Medicine, Sinai Health, University Health Network, and University of Toronto, Toronto, Ontario, Canada.
Grover SA; Division of Clinical Epidemiology, Department of Medicine, McGill University, Montréal, Québec, Canada.; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Murthy S; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Jan 19; Vol. 9 (3), pp. ofac008. Date of Electronic Publication: 2022 Jan 19 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
Autorzy:
Nadeau ME; Centre for Innovation and Research in Aging, Fredericton, NB, Canada.
Henry JL; Centre for Innovation and Research in Aging, Fredericton, NB, Canada.
Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada.
Bortolussi-Courval É; Department of Experimental Medicine, McGill University, Montréal, QC, Canada.
Goodine C; Horizon Health Network, Fredericton, NB, Canada.; Faculty of Health Professions, College of Pharmacy, Dalhousie University, Halifax, NS, Canada.
McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada. emily.mcdonald@mcgill.ca.; Centre for Outcomes Research and Evaluation, 5252 De Maisonneuve Office 3E.03, Montréal, QC, Canada. emily.mcdonald@mcgill.ca.
Pokaż więcej
Źródło:
Trials [Trials] 2021 Nov 02; Vol. 22 (1), pp. 763. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Deprescriptions*
Aged ; Electronics ; Humans ; Nursing Homes ; Outcome Assessment, Health Care ; Polypharmacy ; Randomized Controlled Trials as Topic ; Software
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Physician Perspectives on Including Pregnant Women in Covid-19 Clinical Trials: Time for a Paradigm Change.
Autorzy:
Trahan MJ; Obstetrics and gynecology resident at McGill University.
Cumyn A; Professor of medicine and an obstetric medicine specialist in the Department of Medicine in the Centre Hospitalier Universitaire de Sherbrooke.
Cheng MP; Assistant professor of medicine and an infectious diseases and medical microbiology specialist in the Department of Medicine at McGill University Health Centre and the Research Institute of the McGill University Health Centre.
McDonald EG; Associate professor of medicine and an internist in the Department of Medicine at McGill University Health Centre and the Research Institute of the McGill University Health Centre.
Lapinsky SE; Professor of medicine and critical care specialist in the Department of Medicine at Mount Sinai Hospital, Toronto.
Daneman N; Clinician scientist and infectious disease specialist in the Department of Medicine at Sunnybrook Health Sciences Centre, Toronto.
Abenhaim HA; Associate professor and maternal-fetal medicine specialist in the Department of Obstetrics and Gynecology at McGill University and in the Department of Obstetrics and Gynecology and Lady David Research Institute at Jewish General Hospital in Montreal.
Malhamé I; Assistant professor of medicine and an obstetric medicine specialist in the Department of Medicine at McGill University Health Centre and the Research Institute of the McGill University Health Centre.
Pokaż więcej
Źródło:
Ethics & human research [Ethics Hum Res] 2021 Nov; Vol. 43 (6), pp. 19-27. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Physicians*
Canada ; Female ; Humans ; Pregnancy ; Pregnant Women ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence.
Autorzy:
McDonald EG; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Canada.
Butler-Laporte G; Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada.
Del Corpo O; Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada.
Hsu JM; Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada.
Lawandi A; Department of Critical Care Medicine, National Institutes of Health, Clinical Center, Bethesda, Maryland, USA.
Senecal J; Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada.
Sohani ZN; Department of Medicine, McGill University, Montréal, Canada.
Cheng MP; Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montréal, Canada.; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Canada.
Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Canada.; Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada.; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Oct 29; Vol. 8 (12), pp. ofab545. Date of Electronic Publication: 2021 Oct 29 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic.
Autorzy:
Pullen MF; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Pastick KA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Williams DA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Nascene AA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Bangdiwala AS; School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Okafor EC; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Hullsiek KH; School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Skipper CP; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Lofgren SM; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Engen N; School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Abassi M; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
McDonald EG; Department of Medicine, McGill University, Montreal, Québec, Canada.
Lee TC; Department of Medicine, McGill University, Montreal, Québec, Canada.
Rajasingham R; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Boulware DR; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Dec 28; Vol. 8 (2), pp. ofaa602. Date of Electronic Publication: 2020 Dec 28 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.
Autorzy:
Lofgren SM; University of Minnesota, Minneapolis, Minnesota, USA.
Nicol MR; University of Minnesota, Minneapolis, Minnesota, USA.
Bangdiwala AS; University of Minnesota, Minneapolis, Minnesota, USA.
Pastick KA; University of Minnesota, Minneapolis, Minnesota, USA.
Okafor EC; University of Minnesota, Minneapolis, Minnesota, USA.
Skipper CP; University of Minnesota, Minneapolis, Minnesota, USA.
Pullen MF; University of Minnesota, Minneapolis, Minnesota, USA.
Engen NW; University of Minnesota, Minneapolis, Minnesota, USA.
Abassi M; University of Minnesota, Minneapolis, Minnesota, USA.
Williams DA; University of Minnesota, Minneapolis, Minnesota, USA.
Nascene AA; University of Minnesota, Minneapolis, Minnesota, USA.
Axelrod ML; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lother SA; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
MacKenzie LJ; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Drobot G; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Marten N; George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada.
Cheng MP; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Zarychanski R; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.; George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada.
Schwartz IS; Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Silverman M; Lawson Research Institute, St. Joseph's Healthcare Center, London, Ontario.
Chagla Z; McMaster University, Hamilton, Ontario, Canada.
Kelly LE; George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada.
McDonald EG; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Lee TC; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Hullsiek KH; University of Minnesota, Minneapolis, Minnesota, USA.
Boulware DR; University of Minnesota, Minneapolis, Minnesota, USA.
Rajasingham R; University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Oct 19; Vol. 7 (11), pp. ofaa500. Date of Electronic Publication: 2020 Oct 19 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series Analysis.
Autorzy:
Butler-Laporte G; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Division of Medical Microbiology, Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Cheng MP; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Division of Medical Microbiology, Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Thirion DJG; Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada.; Department of Pharmacy, McGill University Health Centre, Montréal, Québec, Canada.
De L'Étoile-Morel S; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Division of Medical Microbiology, Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Frenette C; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Division of Medical Microbiology, Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Paquette K; Division of Neonatology, Department of Pediatrics, McGill University Health Centre, Montréal, Québec, Canada.
Lawandi A; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Division of Medical Microbiology, Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montréal, Québec, Canada.
McDonald EG; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, Québec, Canada.
Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, Québec, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Sep 24; Vol. 7 (11), pp. ofaa449. Date of Electronic Publication: 2020 Sep 24 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials.
Autorzy:
Pastick KA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Nicol MR; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Smyth E; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Québec, Canada.
Zash R; Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Boulware DR; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Rajasingham R; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Québec, Canada.; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Québec, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Aug 13; Vol. 7 (9), pp. ofaa350. Date of Electronic Publication: 2020 Aug 13 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Radiographic features in investigated for Pneumocystis jirovecii pneumonia: a nested case-control study.
Autorzy:
Hsu JM; Faculty of Medicine, McGill University, Montreal, Canada.
Hass A; Faculty of Medicine, McGill University, Montreal, Canada.
Gingras MA; Department of Medicine, McGill University, Montreal, Canada.
Chong J; Department of Radiology, McGill University, Montreal, Canada.
Costiniuk C; Department of Medicine, McGill University, Montreal, Canada.; Clinical Practice Assessment Unit, McGill University Health Centre, Montreal, Canada.; McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Canada.
Ezer N; Department of Medicine, McGill University, Montreal, Canada.
Fraser RS; Department of Pathology, McGill University, Montreal, Canada.
McDonald EG; Department of Medicine, McGill University, Montreal, Canada.; Clinical Practice Assessment Unit, McGill University Health Centre, Montreal, Canada.; McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Canada.
Lee TC; Department of Medicine, McGill University, Montreal, Canada. .; Clinical Practice Assessment Unit, McGill University Health Centre, Montreal, Canada. .; McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Canada. .; McGill University Health Centre / Royal Victoria Hospital, McGill University, 1001 Décarie Blvd, E5.1820, Montreal, QC, H4A 3J1, Canada. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Jul 10; Vol. 20 (1), pp. 492. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji:
Controlled Clinical Trial; Journal Article
MeSH Terms:
Tomography, X-Ray Computed*
Pneumonia, Pneumocystis/*diagnostic imaging
Aged ; Case-Control Studies ; Cohort Studies ; Humans ; Logistic Models ; Middle Aged ; Pneumonia, Pneumocystis/pathology ; Radiography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19).
Autorzy:
Pastick KA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Okafor EC; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Wang F; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Lofgren SM; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Skipper CP; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Nicol MR; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Pullen MF; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Rajasingham R; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Canada.
Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Canada.
Schwartz IS; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta.
Kelly LE; Department of Pediatrics and Child Health, Department of Pharmacology, University of Manitoba, Winnipeg, Canada.
Lother SA; Department of Medicine, Sections of Critical Care and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
Mitjà O; Fight AIDS and Inf Dis Foundation, Hospital Germans Trias i Pujol, Barcelona, Spain.
Letang E; Department of Infectious Diseases, Hospital del Mar/Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; ISGlobal, Barcelona Institute for Global Health, Universitat de Barcelona, Barcelona, Spain.
Abassi M; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Boulware DR; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Apr 15; Vol. 7 (4), pp. ofaa130. Date of Electronic Publication: 2020 Apr 15 (Print Publication: 2020).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low-Dose TMP-SMX in the Treatment of Pneumocystis jirovecii Pneumonia: A Systematic Review and Meta-analysis.
Autorzy:
Butler-Laporte G; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Smyth E; Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
Amar-Zifkin A; Medical Libraries, McGill University Health Centre, Montréal, Québec, Canada.
Cheng MP; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
McDonald EG; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.; McGill Interdisciplinary Initiative in Infection and Immunity, McGill University Health Centre, Montréal, Québec, Canada.; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.; McGill Interdisciplinary Initiative in Infection and Immunity, McGill University Health Centre, Montréal, Québec, Canada.; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Apr 02; Vol. 7 (5), pp. ofaa112. Date of Electronic Publication: 2020 Apr 02 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An online educational module on transfusion safety and appropriateness for resident physicians: a controlled before-after quality-improvement study.
Autorzy:
Lee TC; Clinical Practice Assessment Unit (Lee, Murray, McDonald) and Division of General Internal Medicine (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
Murray J; Clinical Practice Assessment Unit (Lee, Murray, McDonald) and Division of General Internal Medicine (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que.
McDonald EG; Clinical Practice Assessment Unit (Lee, Murray, McDonald) and Division of General Internal Medicine (Lee, McDonald), Department of Medicine, McGill University Health Centre, Montréal, Que. emily.mcdonald@mcgill.ca.
Pokaż więcej
Źródło:
CMAJ open [CMAJ Open] 2019 Jul 25; Vol. 7 (3), pp. E492-E496. Date of Electronic Publication: 2019 Jul 25 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 23

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies